STING1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD patients, STING activation is associated with development of liver inflammation and fibrosis by monocyte-derived macrophages, indicating that STING contributes to the progression of NAFLD (Figure 5(C)).